Cage Bio Overview
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$11M
- Investors
-
7
Cage Bio General Information
Description
Developer of an eutectic ionic liquid designed to minimize the pervasive use of systemic drugs for the treatment of dermal diseases and symptoms. The company offers a product that is based on ionic liquid technology, which offers broad-spectrum antimicrobial and anti-inflammatory properties along with enhancement of solubility and permeability, enabling physicians to treat dermal diseases successfully and effectively using effective products for dermatology.
Contact Information
Website
www.cagebio.comCorporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
Cage Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 29-Apr-2025 | $11M | Completed | Clinical Trials - Phase 2 | ||
| 6. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 | ||||
| 5. Early Stage VC (Series A2) | 27-Oct-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC (Series A) | 16-Feb-2021 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series B) | 28-Jun-2019 | Completed | Clinical Trials - Phase 2 | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 05-Jul-2018 | Completed | Startup |
Cage Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 3,838,471 | $0.001000 | $2.61 | $2.61 | 1x | $2.61 | 11.75% | |
| Seed | 1,845,541 | $0.001000 | $0.18 | $0.18 | 1x | $0.18 | 5.65% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cage Bio Patents
Cage Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4836784-A1 | Topical compositions containing tofacitinib and ionic liquid | Pending | 07-Jan-2025 | ||
| US-20260265761-A1 | Topical compositions containing aptamer and ionic liquid | Pending | 18-Oct-2024 | ||
| WO-2026085544-A1 | Topical compositions containing aptamer and ionic liquid | Pending | 18-Oct-2024 | ||
| AU-2025205671-A1 | Topical compositions containing tofacitinib and ionic liquid | Pending | 07-Jan-2024 | ||
| US-20260272822-A1 | Topical compositions containing tofacitinib and ionic liquid | Pending | 07-Jan-2024 | A61K9/0014 |
Cage Bio Signals
Cage Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cowtown Angels | Angel Group | Minority | ||
| AG Collective Capital | Venture Capital | Minority | ||
| TexCag | Corporation | Minority | ||
| CKG Management | Venture Capital | Minority | ||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator |
Cage Bio FAQs
-
Where is Cage Bio headquartered?
Cage Bio is headquartered in San Carlos, CA.
-
What is the size of Cage Bio?
Cage Bio has 10 total employees.
-
What industry is Cage Bio in?
Cage Bio’s primary industry is Biotechnology.
-
Is Cage Bio a private or public company?
Cage Bio is a Private company.
-
What is Cage Bio’s current revenue?
The current revenue for Cage Bio is .
-
How much funding has Cage Bio raised over time?
Cage Bio has raised $57.6M.
-
Who are Cage Bio’s investors?
Cowtown Angels, AG Collective Capital, TexCag, CKG Management, and Johnson & Johnson Innovation - JLABS are 5 of 7 investors who have invested in Cage Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process